Ecotin

Exploring a feasible antithrombotic profile

Luciana Serrão Wermelinger, Flávia Serra Frattani, Tatiana Lobo, Charles S. Craik, Helena Carla Castro, Russolina Benedeta Zingali

Research output: Contribution to journalArticle

Abstract

Ecotin is an Escherichia coli-derived protein that can inhibit serine proteases. It has been suggested that this protein (ecotin-WT) and some of its variants could be used to develop a prototype to treat thrombosis. In this work, the effect of ecotin-WT and a variant of this protein harboring two mutations (Met84Arg and Met85Arg, ecotin-RR) were analyzed to determine their ability to prevent thrombus formation using in vivo models. Ecotins were analyzed in vitro using the coagulation tests. An in vivo venous thrombosis rat model and a pulmonary thromboembolism mouse model were used to investigate the antithrombotic activity. The bleeding time in rats using a tail-transection model was evaluated as a possible side effect caused by the administration of these proteins. Ecotin-RR was more effective in inhibiting thrombin than ecotin-WT. Both ecotins presented similar mechanisms of anticoagulation activity and were able to decrease thrombus formation. In contrast, only ecotin-RR increased survival rates in the in vivo pulmonary thromboembolism model, reinforcing the antithrombotic activity of ecotin-RR. Ecotin-WT and more so ecotin-RR showed potent antithrombotic effects, not associated with bleeding. The presented results indicate that ecotin-WT and ecotin-RR may be new scaffolds that could be used to develop anticoagulation molecules.

Original languageEnglish
Pages (from-to)296-303
Number of pages8
JournalInternational Journal of Biological Macromolecules
Volume78
DOIs
Publication statusPublished - 1 Jul 2015
Externally publishedYes

Fingerprint

Thrombosis
Pulmonary Embolism
Proteins
Bleeding Time
Escherichia coli Proteins
Serine Proteases
Rats
Thrombin
Venous Thrombosis
Tail
Hemorrhage
Mutation
Coagulation
Scaffolds
Escherichia coli
Molecules
In Vitro Techniques

Keywords

  • Ecotin
  • Factor xa inhibitor
  • Thrombin inhibitor

ASJC Scopus subject areas

  • Structural Biology
  • Biochemistry
  • Molecular Biology

Cite this

Wermelinger, L. S., Frattani, F. S., Lobo, T., Craik, C. S., Castro, H. C., & Zingali, R. B. (2015). Ecotin: Exploring a feasible antithrombotic profile. International Journal of Biological Macromolecules, 78, 296-303. https://doi.org/10.1016/j.ijbiomac.2015.03.071

Ecotin : Exploring a feasible antithrombotic profile. / Wermelinger, Luciana Serrão; Frattani, Flávia Serra; Lobo, Tatiana; Craik, Charles S.; Castro, Helena Carla; Zingali, Russolina Benedeta.

In: International Journal of Biological Macromolecules, Vol. 78, 01.07.2015, p. 296-303.

Research output: Contribution to journalArticle

Wermelinger, Luciana Serrão ; Frattani, Flávia Serra ; Lobo, Tatiana ; Craik, Charles S. ; Castro, Helena Carla ; Zingali, Russolina Benedeta. / Ecotin : Exploring a feasible antithrombotic profile. In: International Journal of Biological Macromolecules. 2015 ; Vol. 78. pp. 296-303.
@article{467ba0d12c084d54a5b09c4ae7b68093,
title = "Ecotin: Exploring a feasible antithrombotic profile",
abstract = "Ecotin is an Escherichia coli-derived protein that can inhibit serine proteases. It has been suggested that this protein (ecotin-WT) and some of its variants could be used to develop a prototype to treat thrombosis. In this work, the effect of ecotin-WT and a variant of this protein harboring two mutations (Met84Arg and Met85Arg, ecotin-RR) were analyzed to determine their ability to prevent thrombus formation using in vivo models. Ecotins were analyzed in vitro using the coagulation tests. An in vivo venous thrombosis rat model and a pulmonary thromboembolism mouse model were used to investigate the antithrombotic activity. The bleeding time in rats using a tail-transection model was evaluated as a possible side effect caused by the administration of these proteins. Ecotin-RR was more effective in inhibiting thrombin than ecotin-WT. Both ecotins presented similar mechanisms of anticoagulation activity and were able to decrease thrombus formation. In contrast, only ecotin-RR increased survival rates in the in vivo pulmonary thromboembolism model, reinforcing the antithrombotic activity of ecotin-RR. Ecotin-WT and more so ecotin-RR showed potent antithrombotic effects, not associated with bleeding. The presented results indicate that ecotin-WT and ecotin-RR may be new scaffolds that could be used to develop anticoagulation molecules.",
keywords = "Ecotin, Factor xa inhibitor, Thrombin inhibitor",
author = "Wermelinger, {Luciana Serr{\~a}o} and Frattani, {Fl{\'a}via Serra} and Tatiana Lobo and Craik, {Charles S.} and Castro, {Helena Carla} and Zingali, {Russolina Benedeta}",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.ijbiomac.2015.03.071",
language = "English",
volume = "78",
pages = "296--303",
journal = "International Journal of Biological Macromolecules",
issn = "0141-8130",
publisher = "Elsevier",

}

TY - JOUR

T1 - Ecotin

T2 - Exploring a feasible antithrombotic profile

AU - Wermelinger, Luciana Serrão

AU - Frattani, Flávia Serra

AU - Lobo, Tatiana

AU - Craik, Charles S.

AU - Castro, Helena Carla

AU - Zingali, Russolina Benedeta

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Ecotin is an Escherichia coli-derived protein that can inhibit serine proteases. It has been suggested that this protein (ecotin-WT) and some of its variants could be used to develop a prototype to treat thrombosis. In this work, the effect of ecotin-WT and a variant of this protein harboring two mutations (Met84Arg and Met85Arg, ecotin-RR) were analyzed to determine their ability to prevent thrombus formation using in vivo models. Ecotins were analyzed in vitro using the coagulation tests. An in vivo venous thrombosis rat model and a pulmonary thromboembolism mouse model were used to investigate the antithrombotic activity. The bleeding time in rats using a tail-transection model was evaluated as a possible side effect caused by the administration of these proteins. Ecotin-RR was more effective in inhibiting thrombin than ecotin-WT. Both ecotins presented similar mechanisms of anticoagulation activity and were able to decrease thrombus formation. In contrast, only ecotin-RR increased survival rates in the in vivo pulmonary thromboembolism model, reinforcing the antithrombotic activity of ecotin-RR. Ecotin-WT and more so ecotin-RR showed potent antithrombotic effects, not associated with bleeding. The presented results indicate that ecotin-WT and ecotin-RR may be new scaffolds that could be used to develop anticoagulation molecules.

AB - Ecotin is an Escherichia coli-derived protein that can inhibit serine proteases. It has been suggested that this protein (ecotin-WT) and some of its variants could be used to develop a prototype to treat thrombosis. In this work, the effect of ecotin-WT and a variant of this protein harboring two mutations (Met84Arg and Met85Arg, ecotin-RR) were analyzed to determine their ability to prevent thrombus formation using in vivo models. Ecotins were analyzed in vitro using the coagulation tests. An in vivo venous thrombosis rat model and a pulmonary thromboembolism mouse model were used to investigate the antithrombotic activity. The bleeding time in rats using a tail-transection model was evaluated as a possible side effect caused by the administration of these proteins. Ecotin-RR was more effective in inhibiting thrombin than ecotin-WT. Both ecotins presented similar mechanisms of anticoagulation activity and were able to decrease thrombus formation. In contrast, only ecotin-RR increased survival rates in the in vivo pulmonary thromboembolism model, reinforcing the antithrombotic activity of ecotin-RR. Ecotin-WT and more so ecotin-RR showed potent antithrombotic effects, not associated with bleeding. The presented results indicate that ecotin-WT and ecotin-RR may be new scaffolds that could be used to develop anticoagulation molecules.

KW - Ecotin

KW - Factor xa inhibitor

KW - Thrombin inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84928560361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928560361&partnerID=8YFLogxK

U2 - 10.1016/j.ijbiomac.2015.03.071

DO - 10.1016/j.ijbiomac.2015.03.071

M3 - Article

VL - 78

SP - 296

EP - 303

JO - International Journal of Biological Macromolecules

JF - International Journal of Biological Macromolecules

SN - 0141-8130

ER -